Get started
Author

Nicolaus Kröger

Observed names: N Kroger, N. Kröger
ORCID: 0000-0001-5103-9966
Observed ORCID: 0000-0001-5103-9966
OpenAlex ID: A5113812953
Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus
2022 · C. Buske, M. Dreyling, et al. · ESMO Open · 58
PDF
aHSCT is superior to alemtuzumab in maintaining NEDA and improving cognition in multiple sclerosis
2021 · Vivien Häußler, Friederike Ufer, et al. · Annals of Clinical and Translational Neurology · 38
PDF
Successful generation of fully human, second generation, anti-CD19 CAR T cells for clinical use in patients with diverse autoimmune disorders
2024 · Dimitrios Mougiakakos, Ranjita Sengupta, et al. · Cytotherapy · 17
PDF
Ruxolitinib Versus Best Available Therapy in Patients With Steroid-Refractory Acute Graft-Versus-Host Disease: Final Analysis From the Randomized Phase III REACH2 Trial
2025 · Mohamad Mohty, Gerard Socié, et al. · Journal of Clinical Oncology · 9
PDF
Erratum: Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT
2017 · M Robin, R Porcher, et al. · Bone Marrow Transplantation · 8
PDF
Stammzelltransplantation bei Multipler Sklerose
2015 · J.-P. Stellmann, K.H. Stürner, et al. · Der Nervenarzt · 3
Fludarabine combined with treosulfan or total body irradiation as a conditioning therapy before allogeneic hematopoietic stem cell transplantation in acute lymphoblastic leukemia. A retrospective matched-pair analysis from the ALWP of the EBMT
2026 · Ryszard Swoboda, Myriam Labopin, et al. · Bone Marrow Transplantation · 1
PDF
Successful Generation of Anti-CD19 CAR T-Cells (KYV-101) for Clinical Use in Patients with Clinically Diverse Autoimmune Disorders
2025 · Dimitrios Mougiakakos, Ranjita Sengupta, et al. · Transplantation and Cellular Therapy · 1
Two cases of probable Neuro-Behçet syndrome treated with autologous HSCT
2026 · Charlotte Schubert, Lea I. Walter, et al. · Frontiers in Immunology
PDF
Length of SARS-CoV-2 shedding in HCT recipients: an Infectious Disease Working Party of EBMT study
2026 · Malgorzata Mikulska, Gloria Tridello, et al. · Bone Marrow Transplantation
Stammzelltransplantation bei Multipler Sklerose - wo stehen wir?
2022 · Christoph Heesen, Max Kaufmann, et al. · InFo Neurologie + Psychiatrie
Stammzelltransplantation bei Multipler Sklerose: Hamburger Erfahrungen und internationaler Forschungsstand
2015 · Jan‐Patrick Stellmann, Klarissa Hanja Stürner, et al. · Der Nervenarzt
Works count: 12
Citation count: 134
H-index: 5
I10-index: 3
Year
Topic
Type